Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis

Status Completed

Clinical Trial Summary

Feasibility trial (FIH) to assess the safety and clinical utility in patients with chronic bronchitis.

Clinical Trial Description

The Gala Airway Treatment system is a device-based, energy delivery system that delivers high frequency short duration energy to the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.

Two sessions of treatment will be delivered one month apart. The right lung is treated at the first treatment session and the left lung is treated at the second treatment session (approximately one month after the right side is treated). Treatment will be delivered by a respiratory physician (interventional pulmonologist) in a tertiary teaching hospital during a bronchoscopic procedure. The bronchoscopy will be delivered during general anaesthesia. It is anticipated that the bronchoscopic procedure will last less than 60 minutes in total. Treatment will be deemed to have been delivered following the successful treatment during the two bronchoscopies.

A third bronchoscopy will be performed three months following the second treatment session where treatment is not delivered but a cryo-biopsy will be taken from the airway sites that have been treated during the two previous bronchoscopic treatment session to evaluate the effect of the treatment on the airways producing excessive mucous.

Subjects will be required to submit to several tests during the study including two CT scans (lung), respiratory function tests, exercise testing. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03107494
Study type	Interventional
Source	Gala Therapeutics, Inc.
Contact
Status	Completed
Phase	N/A
Start date	January 20, 2017
Completion date	November 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05533931` - Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis	N/A
Completed	`NCT01420445` - Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis	Phase 2
Completed	`NCT01071161` - The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough	Phase 3
Completed	`NCT00903955` - Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease	N/A
Terminated	`NCT00524095` - Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis	Phase 2
Completed	`NCT00129883` - Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals	N/A
Recruiting	`NCT05075083` - Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD	Phase 4
Recruiting	`NCT05075057` - Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD	Phase 4
Terminated	`NCT02838108` - The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
Completed	`NCT02128529` - Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)	N/A
Withdrawn	`NCT00298402` - Macrophages in Smokers' Lung	N/A
Completed	`NCT00298389` - Macrophage Phagocytosis in COPD
Terminated	`NCT00132951` - KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections	Phase 4
Active, not recruiting	`NCT01969344` - Study of COPD Subgroups and Biomarkers
Completed	`NCT00680056` - Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients	Phase 4
Completed	`NCT00106080` - Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)	N/A
Completed	`NCT00042718` - A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.	Phase 3
Completed	`NCT02099799` - The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD	N/A
Completed	`NCT00342030` - Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans	N/A
Withdrawn	`NCT02341183` - Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects	N/A